MONITORING OF LONG-TERM ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B

Código QR

MONITORING OF LONG-TERM ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B

.

Guardado en:

Detalles Bibliográficos
Autores principales:	A. A. Sukhoruk, K. A. Zakharov
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/ff19cad7206a40868f537d6b84661457
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

VIRAL HEPATITIS B AND C IN THE ARKHANGELSK REGION: LONG-TERM DYNAMICS OF INCIDENCE AND CROSS-SECTIONAL STUDY OF MARKERS AMONG ADULT POPULATION
por: T. V. Balaeva, et al.
Publicado: (2018)

FEATURES OF THE SUBPOPULATION COMPOSITION CYTOTOXIC T-LYMPHOCYTES IN CHILDREN WITH CONGENITAL CHRONIC HEPATITIS B
por: O. K. Batsunov, et al.
Publicado: (2018)

PARENTERAL VIRAL HEPATITIS IN CHILDREN IN RUSSIA, PARTICULARLY IN THE NORTHWESTERN FEDERAL DISTRICT
por: A. A. Sukhoruk, et al.
Publicado: (2018)

HEPATITIS A PREVALENCE AMONG CHILDREN IN BOKE AND KINDIA PROVINCES (REPUBLIC OF GUINEA)
por: E. V. Esaulenko, et al.
Publicado: (2018)

SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS
por: G. V. Lukmanova, et al.
Publicado: (2018)

CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
por: A. Budkowska
Publicado: (2018)

IMMUNOGENICITY OF THE THIRD GENERATION HEPATITIS B VACCINE (pre-S1/pre-S2/S)
por: E. V. Esaulenko, et al.
Publicado: (2018)

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
por: Vicente Soriano, et al.
Publicado: (2022)

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
por: D. E. Valutite, et al.
Publicado: (2018)

EPIDEMIOLOGICAL CHARACTERISTICS OF INCIDENCE OF CHRONIC VIRAL HEPATITIS B INFECTION AMONG HEALTHCARE WORKERS IN ST. PETERSBURG IN 2013–2017
por: D. V. Vasilyev, et al.
Publicado: (2018)

MOLECULAR-GENETIC CHARACTERISTICS OF THE HEPATITIS B IN THE NANAYSKY DISTRICT OF THE KHABAROVSK TERRITORY
por: V. O. Kotova, et al.
Publicado: (2018)

FREQUENCY AND THE CLINICAL SIGNIFICANCE OF OCCULT HEPATITIS B VIRUS INFECTION
por: E. V. Esaulenko, et al.
Publicado: (2018)

HIGH BURDEN OF HEPATITIS B IN VIETNAM: IMPACT OF A HIGHLY HETEROGENEOUS VIRAL POPULATION
por: O. V. Kalinina, et al.
Publicado: (2018)

PCR ANALYSIS IN THE REAL TIME REGIMEN AS A LONG-TERM METHOD FOR LABORATORY DIAGNOSIS OF RICKETTSIOSIS
por: E. E. Alieva, et al.
Publicado: (2018)

HEPATITIS B VIRUS IDENTIFICATION IN THE ENSURING INFECTIOUS SAFETY OF BLOOD TRANSFUSIONS
por: Yu. V. Ostankova, et al.
Publicado: (2018)

THE DRUG RESISTANCE MUTATIONS OF THE HEPATITIS B VIRUS AMONG HIV-INFECTED INDIVIDUALS
por: Yu. V. Ostankova
Publicado: (2018)

DEPENDENCE OF THE PHENOTYPIC COMPOSITION OF T-LYMPHOCYTES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C ON THE VIRUS GENOTYPE (IN DYNAMICS OF TREATMENT OF MEDICINES OF DIRECT ANTIVIRAL ACTION)
por: A. Borisov, et al.
Publicado: (2019)

LOW HEPATITIS B VIRUS DNA BURDEN DOES NOT ALWAYS PROTECT FROM LIVER CANCER DEVELOPMENT
por: P. Pineau
Publicado: (2018)

Clinical severe acute respiratory syndrome coronavirus 2 isolation and antiviral testing
por: Gregory Mathez, et al.
Publicado: (2021)

MONITORING OF VACCINAL PROCESS IN HUMANS RESIDING IN THE ALTAI HIGH-MOUNTAINOUS NATURAL PLAGUE FOCUS
por: K. M. Korytov, et al.
Publicado: (2018)

INFORMATION TECHNOLOGY APPLICATION FOR NATURAL FOCI INFECTIONS MONITORING AND PREDICTION
por: A. V. Burdakov, et al.
Publicado: (2018)

Primary CNS lymphoma in immunocompetent chinese patients and the association with chronic Hepatitis B
por: B. Noor, et al.
Publicado: (2016)

Development of antiviral therapeutics combating coxsackievirus type B3 infection
por: A. S. Volobueva, et al.
Publicado: (2021)

MONITORING VECTORS OF TICK-BORNE BORRELIOSIS, HUMAN GRANULOCYTIC ANAPLASMOSIS, HUMAN MONOCYTIC EHRLICHIOSIS IN STAVROPOL REGION IN 2017
por: K. A. Purmak, et al.
Publicado: (2018)

MICROBIOLOGICAL MONITORING OF THE RESISTANCE OF HOSPITAL BACTERIAL FLORA WITHIN THE SYSTEM OF PREVENTION OF HEALTHCARE-ASSOCIATED INFECTIONS
por: N. V. Shestopalov, et al.
Publicado: (2018)

CURRENT PROBLEMS IN DIAGNOSTICS AND TREATMENT OF STRONGULOIDIASIS
por: A. K. Tokmalayev, et al.
Publicado: (2018)

RISK FACTORS OF PERINATAL TRANSMISSION OF HEPATITIS C VIRUS
por: T. V. Znovets, et al.
Publicado: (2018)

DEVELOPMENT OF A PANEL OF MONOCLONAL ANTIBODIES FOR STUDYING OF LOCAL PRODUCTION OF CYTOKINES IN CHRONIC RHINOSINUSITIS
por: E. A. Varyushina, et al.
Publicado: (2018)

RECONSTRUCTION OF RECOMBINATION SITES IN GENOMES OF GENOTYPE 2 HEPATITIS C VIRUS STRAINS USING BIOINFORMATICS METHODS
por: A. I. Paramonov, et al.
Publicado: (2018)

THE OCCURENCE OF HEPATITIS C MARKERS AMONG RESIDENTS OF THE KINDIA PREFECTURE OF THE REPUBLIC OF GUINEA AND THE KHANH HOA PROVINCE OF VIET NAM
por: E. V. Lichnaia, et al.
Publicado: (2018)

CYTOKINES AND CHEMOKINES IN THE BLOOD PLASMA OF PATIENTS WITH CHRONIC HEPATITIS C
por: K. A. Sysoev, et al.
Publicado: (2014)

EPIDEMIOLOGICAL MONITORING OF POLIOMYELITIS IN THE CENTRAL AFRICAN REPUBLIC FROM 2004 TO 2017 AND IMPLEMENTATION OF POLIOVIRUS ENVIRONMENTAL SURVEILLANCE IN BANGUI IN 2017
por: J. Doté, et al.
Publicado: (2018)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Anna L McNaughton, et al.
Publicado: (2021)

PATHOGENETIC TREATMENT OF SEVERE P. FALCIPARUM MALARIA: APPROACHES TO OPTIMIZATION
por: A. K. Tokmalayev, et al.
Publicado: (2018)

EFFICIENCY OF IMMUNOCORRECTION IN СHRONIC VIRAL HEPATITIS C PATIENTS TREATED BY ANTIVIRALS
por: L. P. Sklyar, et al.
Publicado: (2014)

THE EFFECT OF PARVOVIRUS B19 INFECTION ON RESULTS OF CHEMOTHERAPY IN PATIENTS WITH LYMPHOMA
por: T. A. Zykova, et al.
Publicado: (2018)

PHYSIOLOGICAL IMPACT OF THE EVOLUTION OF THE rpoB MUTATION
por: M. Grobbelaar, et al.
Publicado: (2018)

CHARACTERISTICS OF A MOBILE LABORATORY FOR MONITORING AND DIAGNOSTICS DURING EPIZOOTOLOGICAL INVESTIGATION IN THE MONGOLIAN PART OF THE TRANSBOUNDARY SAILUGEM PLAGUE FOCUS
por: E. N. Rozhdestvensky, et al.
Publicado: (2018)

DIAGNOSIS OF CYTOMEGALOVIRUS AND PARVOVIRUS B19 INFECTIONS IN SPECIAL GROUPS OF PATIENTS
por: V. M. Semenov, et al.
Publicado: (2018)

IN MEMORY OF ANATOLIJ B. ZHEBRUN
por: article Editorial
Publicado: (2015)